Drug Discovery World

DECEMBER 6, 2023

It intends to set amended payment percentages for 2024 to 2026 based on an allowed growth rate that has been increased to 2%. This means that companies will pay a rebate on the sales of branded medicines to the NHS of 21.9% in 2024, 24% in 2025 and 26.8%

Government 147

Government Pharma Companies Science International 147

Drug Discovery World

OCTOBER 4, 2022

DDW Editor Reece Armstrong explores some of the trends that will be featured in sessions throughout ELRIG Drug Discovery 2022 and the news behind them. Automated systems have become a prominent feature throughout drug discovery, helping scientists save time and assisting in reproducible experiments for more verifiable results.

Drugs 130

Drugs Therapies Clinical Trials Cell Based Assays 130

Drug Discovery World

FEBRUARY 2, 2024

AI in drug discovery Answering the question of where technology is being implemented to progress the drug discovery process, Tarselli says: “You know that what everyone wants to say right now is AI (artificial intelligence). This session will ask, have you used AI and ML to generate actual outcomes for a drug process?

Compliance 130

Compliance Science Pharma Companies Engineering 130

Drug Discovery World

JANUARY 24, 2024

Wigerinck has taken four drugs (Prezista, Olysio, Jyseleca and Rekambys) to market. Phase I of the clinical program will dose healthy volunteers with single ascending doses of FIB992 before proceeding to a multiple ascending dose study where the drug is administered for a two-week period.

Small Molecule 147

Small Molecule Research Pharma Companies Disease 147